Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride
Status:
Completed
Trial end date:
2016-02-22
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the effect of a fixed dose combination of
vildagliptin plus metformin versus combination therapy of glimepiride plus metformin in
glycemic variability in patients with type 2 diabetes who have not achieved adequate control
of their disease prior to treatment with metformin monotherapy in optimal doses.